Leerink Partners Adjusts Price Target on IQVIA to $267 From $278, Maintains Outperform Rating
Baird Adjusts Price Target on IQVIA to $235 From $241
Baird Maintains Neutral on IQVIA Hldgs, Lowers Price Target to $235
IQVIA Hldgs Analyst Ratings
Evercore ISI Group Maintains Outperform on IQVIA Hldgs, Lowers Price Target to $230
Evercore ISI Adjusts Price Target on IQVIA Holdings to $230 From $250, Maintains Outperform Rating
IQVIA Hldgs Analyst Ratings
Barclays Lowers Price Target on IQVIA Holdings to $255 From $275
IQVIA Hldgs Analyst Ratings
Goldman Sachs Initiates IQVIA With Buy Rating, $270 Price Target
IQVIA Holdings (IQV) Gets a Buy From Jefferies
Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), CVS Health (CVS)
Stifel Nicolaus Keeps Their Buy Rating on IQVIA Holdings (IQV)
Stifel Adjusts Price Target on IQVIA Holdings to $288 From $294
UBS Adjusts Price Target on IQVIA Holdings to $295 From $300, Maintains Buy Rating
Truist Securities Maintains Buy on IQVIA Hldgs, Lowers Price Target to $292
Buy Rating Affirmed for IQVIA Holdings Amidst Strong Growth and Resilient Demand
IQVIA Holdings (IQV) Receives a Buy From Truist Financial
Evercore ISI Adjusts Price Target on IQVIA to $250 From $275
IQVIA Hldgs Analyst Ratings